Biomarkers predictive of lymph node metastases in oral squamous cell carcinoma

被引:33
作者
Lopes, MA
Nikitakis, NG
Reynolds, MA
Ord, RA
Sauk, J
机构
[1] Univ Maryland, Sch Dent, Baltimore, MD 21201 USA
[2] UNICAMP, Fac Odontol Piracicaba, Sao Paulo, Brazil
[3] Univ Maryland, Greenebaum Canc Ctr, Baltimore, MD USA
基金
巴西圣保罗研究基金会;
关键词
D O I
10.1053/joms.2002.29804
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Purpose: The ability of oral squamous cell carcinoma to metastasize to lymph nodes does not always show a relationship with clinical staging. The aim of this stud), was to attempt to define a trend for predictive histopathologic and/or molecular biomarkers in the development of nodal metastasis by analyzing 2 clinically extreme groups. Patients and Methods: Patients with small primary tumors (T1, T2) with lymph node metastasis and patients with large primary tumors (T3, T4) without metastatic disease were identified among 315 consecutive cases of primary oral squamous cell carcinoma. Group comparisons were made with use of a Mann-Whitney test, and associations among the variables were assessed with nonparametric and parametric correlational analyses. Results: The degree of keratinization was significantly less in primary tumors with lymph node metastasis (Pless than or equal to.01). The degree of keratinization was significantly associated with nuclear pleomorphism (P =.02), number of mitoses (P =.02), stage of invasion (P =.002), and p53 expression (P =.04), independent of clinical stage of the tumor. Other microscopic features and immunohistochemical markers did not differ significantly between the groups (P >.05). Conclusion: These data indicate that there still is no single predictive parameter superior to the degree of keratinization to identify patients at risk for the development of regional metastasis. (C) 2002 American Association of Oral and Maxillofacial Surgeons.
引用
收藏
页码:142 / 147
页数:6
相关论文
共 36 条
[11]  
Hosal AS, 1998, EUR ARCH OTO-RHINO-L, V255, P216
[12]   EMS1 gene expression in primary breast cancer:: relationship to cyclin D1 and oestrogen receptor expression and patient survival [J].
Hui, R ;
Ball, JR ;
Macmillan, RD ;
Kenny, FS ;
Prall, OWJ ;
Campbell, DH ;
Cornish, AL ;
McClelland, RA ;
Daly, RJ ;
Forbes, JF ;
Blamey, RW ;
Musgrove, EA ;
Robertson, JFR ;
Nicholson, RI ;
Sutherland, RL .
ONCOGENE, 1998, 17 (08) :1053-1059
[13]   PATTERNS OF DNA AMPLIFICATION AT BAND-Q13 OF CHROMOSOME-11 IN HUMAN BREAST-CANCER [J].
KARLSEDER, J ;
ZEILLINGER, R ;
SCHNEEBERGER, C ;
CZERWENKA, K ;
SPEISER, P ;
KUBISTA, E ;
BIRNBAUM, D ;
GAUDRAY, P ;
THEILLET, C .
GENES CHROMOSOMES & CANCER, 1994, 9 (01) :42-48
[14]  
Kaur J, 1998, INT J CANCER, V79, P370, DOI 10.1002/(SICI)1097-0215(19980821)79:4&lt
[15]  
370::AID-IJC11&gt
[16]  
3.0.CO
[17]  
2-9
[18]   THE 1993 WALTER-HUBERT-LECTURE - THE ROLE OF THE P53 TUMOR-SUPPRESSOR GENE IN TUMORIGENESIS [J].
LEVINE, AJ ;
PERRY, ME ;
CHANG, A ;
SILVER, A ;
DITTMER, D ;
WU, M ;
WELSH, D .
BRITISH JOURNAL OF CANCER, 1994, 69 (03) :409-416
[19]  
LINDBERG R, 1972, CANCER, V29, P1446, DOI 10.1002/1097-0142(197206)29:6<1446::AID-CNCR2820290604>3.0.CO
[20]  
2-C